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SplicingTranscriptional activity of hypoxia-induced factor 1 (HIF1) – a heterodimer of HIF1α and ARNT (HIF1β) – is
essential for cellular adaptation to environmental stress and plays an important role in skin development,
wound healing, tumorigenesis and barrier function. Using primary mouse and human epidermal
keratinocytes at ambient or hypoxic (1% O2) conditions we studied effects of hypoxia upon HIF protein
expression. Signiﬁcant nuclear levels of ARNT and HIF1α along with high HIF1 activity in normoxic
keratinocytes suggest an as yet uncharacterised oxygen-independent role for HIF pathway in the epidermis.
Acute hypoxia results in an instant but transient increase of HIF1α protein accompanied by a gradual decrease
in its mRNA, while ARNT expression remains unchanged. In prolonged (chronic) hypoxia both HIF1α and Arnt
are downregulated along with decline of HIF1 activity. However, expression of classical HIF1 targets such as
Selenbp1 and Vegfa remains high. Thus, keratinocytes respond to acute hypoxia with immediate block of
HIF1α protein degradation and concomitant increase of HIF activity, while under chronic hypoxia pro-
angiogenic signalling is maintained through HIF1-independent pathway(s). Decline of HIF1α during chronic
exposure is controlled at both mRNA and protein levels, while Arnt is downregulated post-translationally.
Distinct transcription levels of Hif1α and Hif3α splice variants under normoxia and their differential response
to hypoxia suggest functional diversity of Hif-α isoforms and highlight the complexity of HIF machinery
control in epidermal keratinocytes.ear translocator; PMK, primary
; VEGA, Vertebrate Genome
+44 1382 496361.
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Adequate cellular response to changing oxygen levels is critical for
all oxygen-breathing species and is tightly linked to such basic aspects
of cell physiology as metabolism, cell cycle control, apoptosis, and cell
signalling. Hypoxia response is primarily regulated through the highly
conserved transcriptional complex HIF1 (hypoxia-induced factor 1)
which represents a heterodimer of two basic helix-loop-helix PAS
proteins—HIF1α and ARNT (aryl hydrocarbon receptor nuclear
translocator also designated as HIF1β subunit) [1].
According to the conventional view, under normoxic conditions
HIF1α is hydroxylated on two key proline residues in its oxygen-
dependent degradation domain by speciﬁc prolyl hydroxylases
encoded by EGLN genes which utilise oxygen as a co-substrate. This
allows recognition of HIF1α by the von Hippel–Lindau tumour
suppressor protein (pVHL) and subsequent degradation of HIF1α by
the pVHL-dependent ubiquitin proteasomal pathway [2]. This
normoxic mechanism results in a rapid turnover of HIF1α with a
half-life less than 5 min [3]. In addition, oxygen-dependent hydrox-ylation of HIF1α on a conserved asparagine residue in its C-terminal
transactivation domain by FIH1 (factor inhibiting HIF1) inhibits HIF1α
binding to the essential co-activators CBP and p300 [4], thus further
reducing HIF1 activity in normoxia [5].
In hypoxic tissues, including growing tumours and healing
wounds, EGLN-driven hydroxylation of HIF1α is compromised, thus
eventually leading to its stabilization, accumulation in the nucleus,
dimerization with ARNT (Fig. 1) and activation of the downstream
hypoxia pathway [6]. HIF1-binding sites (5′-ACGTGCT-3′ hypoxia
response element or HRE) have been identiﬁed in promoter regions of
genes coding for, among others, various glycolytic enzymes, vascular
endothelial growth factors, nitric oxide synthase, heme oxygenase,
and tyrosine hydroxylase. Therefore, HIF1 represents a global
regulator of key aspects of hypoxia response such as anaerobic
metabolism, erythropoiesis, angiogenesis, vasodilation, and possibly
breathing [7].
The intricacy of HIF pathway was further magniﬁed by identiﬁca-
tion of a number of PAS homologues for HIF1α and ARNT such as
HIF2α, HIF3α, ARNT2, ARNT-like and ARNT-like2 (Fig. 1). In addition,
at least two alternatively spliced isoforms of Hif1α have been
identiﬁed in mice [8] which are not only differentially regulated
[9,10] but also seem to differentially transactivate key targets of HIF1
activity such as Vegf genes [11]. Most HIF/ARNT proteins, their
isoforms and splice variants have different spatial and temporal
expression patterns and are implicated in a complex and still poorly
Fig. 1. Transcriptional activity of HIF-α/ARNT heterodimers in control of normal skin functions and disease. b-HLH, basic helix-loop-helix domain; LZIP, leucine zipper; NLS, nuclear
localisation signal domain; TAD, transactivation domain.
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exceptionally efﬁcient in controlling vital cell functions. This efﬁcien-
cy is achieved, at least in part, through high redundancy of the system.
For example, HIF1α activity can also be regulated by a hypoxia-
dependent splice variant of HIF3α called inhibitory PAS domain
protein (IPAS). IPAS forms an inactive complex with HIF1α which
does not recognize the HRE, thus functioning as a dominant negative
regulator of the HIF1 pathway under hypoxic conditions [16]. Another
mouse splice variant of HIF3α, NEPAS (neonatal and embryonic PAS),
competes with HIF1α and HIF2α for ARNT, thus effectively suppres-
sing their activity in endothelial cells [17].
Hypoxia is a key factor of tumour microenvironment and
signiﬁcantly affects tumour aggressiveness and susceptibility to
anticancer therapy [18,19]. This is why PAS proteins and their
interactions are among the main targets of chemoprevention
[20,21]. Hypoxia and PAS protein activity are also essential for
skin function, playing an important role in wound healing [22,23]
and pathogenesis of certain common skin disorders such as
psoriasis and cancer [24–27]. Moderate hypoxia is a feature of
normal epidermis and correlates with the process of keratinocyte
terminal differentiation [28], while modulation of Arnt in the
epidermis severely affects normal skin development and functioning
[29,30]. Nevertheless, the signals and mechanisms controlling HIF/
ARNT activity in the skin remain unknown. Recent data on
epidermis-mediated constriction of dermal vasculature under
hypoxia [31] suggests that control of HIF activity in the skin may
be distinct compared to other organs and tissues. These facts
together with our ﬁndings that the level of ARNT in human and
mouse skin is a subject of signiﬁcant spatial and developmental
variations [30] add even more complexity to the processes
controlling HIF machinery in the skin.
In order to deﬁne the role of hypoxia in control of PAS proteins and
HIF pathway activity in the epidermis we performed expressional
studies in primarymouse and humanN-TERT epidermal keratinocytesexposed to ambient oxygen (21% O2) or hypoxic conditions (1% O2).
Here we present evidence for a hypoxia-independent role for HIF1 in
epidermal keratinocytes and show that pro-angiogenic signalling
under chronic hypoxia is HIF1-independent. This suggests that
keratinocyte response to acute and chronic hypoxia is regulated
through different mechanisms. Our studies also revealed speciﬁc
patterns of Hif1α and Hif3α splice variant expression in normoxic
keratinocytes and their differential regulation by hypoxia, thus
highlighting the complexity of HIF machinery control in the epidermis
and outlining future steps in exploration of this essential but still
poorly understood regulatory system.
2. Materials and methods
2.1. Cell culture and treatment
Human N-TERT epidermal keratinocytes immortalized by hTERT
expression (a kind gift of James Rheinwald, Harvard Skin Disease
Research Centre, Harvard Medical School, USA), were maintained in
GIBCO keratinocyte serum-free medium at 0.4 mM Ca2+ [32]. Primary
mouse keratinocytes (PMK) were isolated from the skin of 2-day-old
C57Bl/6J mouse newborns (Charles River, East Lothian, UK) and
routinely cultured on collagen in six-well plates in the medium
containing 0.05 mM Ca2+ as we previously described [30].
At conﬂuency, half of the wells were switched to medium
containing a higher level of Ca2+ (1.2 mM for PMK and 1.4 mM for
N-TERT) and cells were subjected to normoxia (21% oxygen) or
hypoxia (1% oxygen) treatment for deﬁned time intervals (between
0.5 and 48 h) in an In Vivo 500 hypoxia workstation (Ruskinn
Technologies, Bridgend, UK) followed by harvesting and analysis. This
gave four experimental groups of cells:
1) NL - cells kept in Normoxia in Low calcium
2) HL - cells kept in Hypoxia in Low calcium
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4) HH - cells kept in Hypoxia in High calcium
2.2. Microarray
For microarray analysis PMK were isolated from 2-day-old female
pups asdescribedaboveon three separateoccasionswith2-week interval.
Every time keratinocyteswere pooled together from at least two separate
litters (3–5 female newborns). Cells were cultured in 6-well plates at low
(0.4 mM) Ca2+ level with the medium being changed every second day.
Upon conﬂuency (day 5) half the cells was transferred into high Ca2+
(1.2 mM) medium and half of cells cultured at high and low Ca2+
conditionswere immediately subjected to hypoxia (1%O2) for 18 h,while
the rest of the cells remained in the normoxic incubator (21% O2). After
exposure, total RNAwas isolated using Qiashredder and RNeasyMini Kits
(Qiagen,West Sussex,UK). RNAwas storedat−80 °C.OnceRNAhadbeen
collected from all three occasions (12 probes in total), it was sent on dry
ice to the PattersonCR-UKmicroarray facility (CR-UK,Manchester)where
it was ampliﬁed and subjected to microarray analysis using Affymetrix
mouse genechip array MOE430.2.0 (www.affymetrix.com).Table 1
Microarray results for genes linked to HIF pathway activity showing probeset number and
HL–NL HH–NH
Hif1a 1431981_at : + 2.73 1431981_at : + 2.1
1448183_a_at : − 1.46 1448183_a_at : − 1
1416035_at : − 1.66 1416035_at : − 1.7
1427418_a_at : − 1.47 1427418_a_at : − 1
Epas1/ Hif2a 1435436_at: + 1.20 1435436_at: + 1.23
1449888_at: + 1.02 1449888_at: + 1.05
Hif3a 1447061_at :+ 5.23 1447061_at : + 4.0
1459052_at + 1.58 1459052_at : + 1.4
1446708_at : + 1.67 1446708_at : + 2.1
1425428_at : + 1.75 1425428_at : + 1.9
1421572_at : + 1.55 1421572_at : + 1.3
1425429_s_at : + 1.21 1425429_s_at : + 1
Hif1an (Fih1) 1452845_at : − 1.05 1452845_at : + 1.1
1447817_at : − 1.20 1447817_at : − 1.1
1428576_at : + 1.10 1428576_at : + 1.0
Arnt 1437042_at : + 1.21 1437042_at : + 1.1
1421721_a_at : + 1.18 1421721_a_at : + 1
1449696_at : + 1.12 1449696_at : + 1.1
1419996_s_at : + 1.10 1419996_s_at : + 1
1425064_at : − 1.02 1425064_at : + 1.1
Arnt2 1420670_at : + 1.02 1420670_at : − 1.0
1420669_at : − 1.09 1420669_at : + 1.0
1434028_at : − 1.04 1434028_at : + 1.1
Arnt1 1425099_a_at : + 1.61 1425099_a_at : + 1
1457740_at : + 1.63 1457740_at : − 1.0
Arntl2 1429688_at : −1.54 1429688_at : −1.88
1425931_a_at : − 1.34 1425931_a_at : −1
Selenbp1 1417580_s_at : + 25.62 1417580_s_at : + 1
1450699_at : + 25.66 1450699_at : + 19
Higd1a 1448359_a_at: + 3.17 1448359_a_at: + 2
1416481_s_at: + 3.12 1416481_s_at: + 2
Vegfa 1420909_at: + 4.02 1420909_at: + 3.20
1451959_a_at: + 3.95 1451959_a_at: + 3
Vegfb 1451803_a_at: + 1.17 1451803_a_at: +1.
Vegfc 1419417_at: + 1.91 1419417_at: + 1.88
1440739_at: + 1.73 1440739_at: + 1.42
1439766_x_at: + 2.70 1439766_x_at: + 2
Nos1 1438483_at: − 1.01 1438483_at: − 1.10
1422949_at: − 1.004 1422949_at: − 1.02
1429887_at: − 1.11 1429887_at: + 1.08
1458626_at: + 1.03 1458626_at: + 1.14
Nos2 1420393_at: + 1.38 1420393_at: + 1.43
Nos3 1422622_at: + 1.16 1422622_at: + 1.14
Epo* – –
Epor 1423344_at: − 1.01 1423344_at: + 1.20
Probesets with signiﬁcant changes (p valueb0.01) are shown in “bold”.
Probesets with insigniﬁcant changes (p valueN0.01) are shown in “smaller font”.
*Epo did not appear even among genes with statistically insigniﬁcant changes.The microarray data were pre-processed using Robust Multi-array
Average (RMA) background correction and normalisation. Compari-
son of the RMA-normalized sample data by Principal Components
Analysis (PCA) revealed clear separation of hypoxic samples from
normoxic ones and, on the other hand, high-Ca2+ from low-Ca2+
samples (not shown). This pattern of sample clustering conﬁrms that
the effects reported in the microarrays were generally due to
consistent changes for the two effects studied, thus justifying the
quality of our microarray data.
The analysis of obtained results was performed using Partek©
Genomics Suite 6.2 (Partek Inc., St. Louis, MO) with ANOVA and t-test,
with multiple testing, as the principal methods. In ANOVA, contrasts
were between low and high Ca2+ levels and between normoxia and
hypoxia. This allowed us to distinguish between effects that were due
to single experimental changes or which were dependent on a
combination of oxygen and Ca2+ status. With p-values of less than
0.01, there were about 10 times more genes in the hypoxia–normoxia
comparisons compared to low-high Ca2+. Results for the individual
comparisons from t-tests for genes relevant to HIF pathway activity
are shown in Table 1.fold change.
NH–NL HH–HL
1 1431981_at : + 1.32 1431981_at : + 1.02
.58 1448183_a_at : − 1.001 1448183_a_at : − 1.08
0 1416035_at : − 1.004 1416035_at : − 1.03
.57 1427418_a_at : + 1.09 1427418_a_at : + 1.02
1435436_at: + 1.52 1435436_at: + 1.48
1449888_at: + 1.25 1449888_at: + 1.22
6 1447061_at : + 1.06 1447061_at : − 1.22
6 1459052_at : − 1.01 1459052_at : − 1.09
1 1446708_at : − 1.04 1446708_at : + 1.22
9 1425428_at : − 1.06 1425428_at : + 1.07
3 1421572_at : + 1.10 1421572_at : − 1.06
.46 1425429_s_at : − 1.13 1425429_s_at : + 1.08
6 1452845_at : − 1.20 1452845_at : + 1.01
1 1447817_at : − 1.10 1447817_at : − 1.03
5 1428576_at : − 1.001 1428576_at : − 1.04
8 1437042_at : + 1.03 1437042_at : + 1.01
.31 1421721_a_at : − 1.02 1421721_a_at : + 1.09
3 1449696_at : + 1.002 1449696_at : + 1.01
.15 1419996_s_at : + 1.02 1419996_s_at : + 1.06
0 1425064_at : − 1.02 1425064_at : + 1.10
2 1420670_at : − 1.08 1420670_at : − 1.13
7 1420669_at : − 1.20 1420669_at : − 1.03
4 1434028_at : − 1.17 1434028_at : + 1.02
.80 1425099_a_at : − 1.13 1425099_a_at : − 1.01
9 1457740_at : + 1.57 1457740_at : − 1.14
1429688_at : − 1.02 1429688_at : − 1.25
.15 1425931_a_at : − 1.11 1425931_a_at : + 1.04
8.69 1417580_s_at : + 1.80 1417580_s_at : + 1.31
.82 1450699_at : + 1.71 1450699_at : + 1.32
.81 1448359_a_at: + 1.20 1448359_a_at: + 1.06
.80 1416481_s_at: + 1.16 1416481_s_at: + 1.04
1420909_at: + 1.40 1420909_at: + 1.11
.42 1451959_a_at: + 1.25 1451959_a_at: + 1.08
16 1451803_a_at: + 1.002 1451803_a_at: − 1.01
1419417_at: − 1.05 1419417_at: − 1.07
1440739_at: − 1.01 1440739_at: − 1.24
.40 1439766_x_at: − 1.03 1439766_x_at: − 1.16
1438483_at: + 1.03 1438483_at: − 1.05
1422949_at: + 1.01 1422949_at: − 1.01
1429887_at: − 1.13 1429887_at: + 1.06
1458626_at: − 1.03 1458626_at: + 1.07
1420393_at: − 1.12 1420393_at: − 1.08
1422622_at: + 1.07 1422622_at: + 1.04
– –
1423344_at: − 1.07 1423344_at: + 1.14
Table 2
The list of qPCR primers.
Gene Sequence 5′-3′ Accession number Source
ARNT sense TGTCATCCTGAAGACCAACAA NM001037737 Designed in house⁎
ARNT antisense AAGGAGCTCGTTCTCATCCA NM001037737 Designed in house
ARNT2 sense CAATGTCAAGCAACTTCA NM007488 Designed by Sigma⁎⁎
ARNT2 antisense TACTGGGACCTGAGATAA NM007488 Designed by Sigma
B2M sense TTCTGGTGCTTGTCTCACTGA NM009735.5 Designed in house
B2M antisense CAGTATGTTCGGCTTCCCATTC NM009735.3 Designed in house
FIH sense CTCATTGGCATGGAAGGAA NM176958.3 Designed by Sigma
FIH antisense TCTCGTAGTCAGGATTGTCA NM176958.3 Designed by Sigma
Hif1α -001/003 (exon 14–15) sense AACAGAATGGAACGGAGCAA NM010431 Designed in house
Hif1α -001/003 (exon 14–15) antisense TCGTAACTGGTCAGCTGTGG NM010431 Designed in house
Hif1α-001 (exon 11–12) Sense TTCAGGAAAACGTAAACACTCC NM010431 Designed in house
Hif1α -001 (exon 11–12) antisense GGGATATAGGGAGCCAGCAT NM010431 Designed in house
Hif1α -003 (exon 1a-2) sense TTCTGGGCAAACTGTTACCG NM010431 Designed in house
Hif1α -003 (exon 1a-2) antisense GGTGACCTCATAACAGAAGC NM010431 Designed in house
Hif1α-001/002/003 (exon 2–3) sense TGCTCATCAGTTGCCACTTG NM010431 Designed in house
Hif1α-001/002/003 (exon 2–3) antisense CCATCTGTGCCTTCATCTCA NM010431 Designed in house
Hif1α-001/002/003 (exon 5–6) sense AACACACAGCGGAGCTTTTT NM010431 Designed in house
Hif1α-001/002/003 (exon 5–6) antisense TTCACAAATCAGCACCAAGC NM010431 Designed in house
Hif1α-002 (3′ UTR) sense GTTTTGGTCTGTAACCCACATGTTC NM010431 Designed in house
Hif1α-002 (3′ UTR) antisense ATTAAGAAAATGGTGTAGGCAGAAA NM010431 Designed in house
Hif1α-002 (exon 6-3′UTR) sense GCTTGGTGCTGATTTGTGAA NM010431 Designed in house
Hif1α-002 (exon 6-3′UTR) antisense TCTTACATTTTTGGGTTCTAGGATG NM010431 Designed in house
Hif2α sense TGTCAACTATGTGCTGAGT NM010137.2 Designed by Sigma
Hif2α antisense CATCGTCACTGCTGTCAA NM010137.2 Designed by Sigma
HIf3α-001 (exon 1–2) sense CATGGACTGGGACCAAGACA NM016868 Designed in house
Hif3α-001 (exon 1–2) antisense CGCAGGTAGCTGATTGTGAG NM016868 Designed in house
Hif3α-001/002/NEPAS (exon 13–14) sense GCTCAGAGGACAAAGGGTTG NM016868 Designed in house
Hif3α-001/002/NEPAS (exon 13–14) antisense AAGGGCTCATGAGAATGCAC NM016868 Designed in house
Hif3α-003/IPAS (exon2-4a) sense AGGTGGAAAAAGGGGGAGAG NM016868 Designed in house
Hif3α-003/IPAS (exon 2-4a) antisense TGGTACCAGGAGTGGGGTTA NM016868 Designed in house
IPAS sense CACTGCTCAGGACATATGAG NM016868.1 Makino et al., 2002; Yamashita et al., 2008
IPAS antisense AGAGAGGATTCAGTCCCTT NM016868.1 Makino et al., 2002; Yamashita et al., 2008
VEGF sense CACCCACGACAGAAGGAGAG NM003376 Designed in house
VEGF antisense ATGTCCACCAGGGTCTCAAT NM003376 Designed in house
⁎ Designed with http://frodo.wi.mit.edu/primer3/.
⁎⁎ Sigma, www.designmyprobe.com.
Table 3
The list of antibodies used for WB.
Antibody Company Cat# Dilution Secondary
Primary
ACTIN Santa Cruz, (Autogen
Bioclear, Wiltshire, UK)
Sc-58673 1:2000 Anti-mouse
ARNT Santa Cruz (Autogen
Bioclear, Wiltshire, UK)
Sc-8076 1:200 Anti-goat
ARNT2 Santa Cruz (Autogen
Bioclear, Wiltshire, UK)
Sc-5581 1:200 Anti-rabbit
FIH Santa Cruz (Autogen
Bioclear, Wiltshire, UK)
Sc-26219 1:200 Anti-goat
Hif1α Genetex (Source Bioscience
Autogen, Nottingham, UK)
GTX30647 1:500 Anti-rabbit
Hif2α Abcam (Cambridge, UK) Ab199 1:500 Anti-rabbit
Secondary
Anti-Mouse Dako (Ely,
Cambridgeshire, UK)
P0447 1:10,000 NA
Anti-Rabbit Dako (Ely,
Cambridgeshire, UK)
P0399 1:20,000 NA
Anti-Goat Jackson ImmunoResearch
(Stratech, Suffolk, UK)
705-035-147 1:40,000 NA
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each other precisely which gives added conﬁdence that we have
highly reproducible data.
2.3. qPCR
Alternatively, total mRNA was isolated using Tri reagent (Sigma,
Dorset, UK) and qPCR performed with Superscript III platinum SYBR
green Onestep qRT-PCR kit (Invitrogen, Paisley, UK) using a MJ Mini
Thermal Cycler (BioRad, Herfordshire, UK). The list of the mouse
primers used for qPCR is shown in Table 2. All qPCR experiments were
performed four times and obtained results were subjected to two-
tailed t-test (two-sample equal variance).
2.4. Protein isolation and Western blotting
Whole cell lysates were obtained using RIPA buffer (50 mM Tris–
HCl, 150 mM NaCl, 1% NP-40, 0.5% Na deoxycholate, 0.1% SDS)
containing 1 mM NaVO3 , 1 mM DTT, 1× protease inhibitor cocktail
(Sigma, Dorset, UK) and 1 mM PMSF in distilled water. Samples were
passed through an 18 G needle, and spun at 10,000 rpm, 10 min at
4 °C. Lysates were stored at −80 °C. Nuclear and cytoplasmic lysates
were obtained as previously described [33]. Brieﬂy, cells were washed
and lysed in the buffer containing 20 mM HEPES, 10 mM KCI, 1 mM
EDTA, 1 mM DL-DTT, 0.2% NP40, 10% glycerol, 1 mM PMSF and 1%
protease inhibitor cocktail in distilled water. Lysates were incubated
for 5 min on ice and then centrifuged for 10 min at 13,000g at 4 °C. The
supernatant (cytosolic fraction) was removed and stored at −80 °C,
while the pellets (nuclear fraction) were resuspended in 50 μl of a
buffer containing 350 mM NaCl, 20% glycerol, 20 mM HEPES, 10 mM
KCl, 1 mM PMSF, and 1% protease inhibitor cocktail. The suspensionwas mixed vigorously with a pipette tip and incubated on ice for
30 min. Samples were then centrifuged for 10 min at 13,000g at 4 °C
and supernatants (nuclear extract) stored at −80 °C.
Whole cell, nuclear and cytoplasmic lysates were analysed for
protein content using the Bradford method (BioRad, Hertfordshire,
UK). Equal amounts of protein (20–50 μg) were added to an equal
volume of Laemmli sample buffer (5% SDS, 25% glycerol, 125 mM Tris,
few grains bromophenol blue, 1mM DTT, pH 8.0) and then subjected
to electrophoresis using a BioRad mini-PROTEAN TGX system with
pre-cast 4–15% gels (456–1083S; BioRad, Hertfordshire, UK) or
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gradient gels (NP0323; Invitrogen, Paisley, UK). Following transfer to
nitrocellulose or PVDF membrane, samples were then subjected to
protein immunoblotting with speciﬁc primary antibodies (Table 3)
diluted in TBS/Tween +3% BSA (Sigma, Dorset, UK) or +1% milk.
Blots were developed with Immobilon Western Chemiluminescent
HRP substrate (Millipore, Hertfordshire, UK) and analysed using X-ray
ﬁlm or the Versadoc Imaging System (BioRad, Hertfordshire, UK).
2.5. VEGF ELISA and TransAm HIF1α assay
VEGF ELISA (ELM VEGF 001C; Raybiotech, Middlesex, UK) was
performed as instructed by the manufacturer using whole cell lysates
in RIPA buffer. VEGF protein levels were assessed at four different
experimental settings combining hypoxia, normoxia and low and high
Ca2+ as described above (see Cell culture and treatment).
TransAm HIF1 Activation Assay (47096; Active Motif, Rixensart,
Belgium) was performed in accordance with manufacturer protocolFig. 2. Hif1α splice variants are differentially regulated by hypoxia in primary mouse keratin
different splice variants of Hif1α with black shading denoting alternative exons and horizo
below. (B) mRNA expression ofHif1α-001 and Hif1α-003 together throughout the acute hypo
exposure (p=0.005). (C) The use of the same primers speciﬁc for both Hif1α-001 and Hif1α
splice variants is signiﬁcantly lower than in corresponding normoxic samples regardless of c
Ca2+; HL, Hypoxia/Low Ca2+; NH, Normoxia/High Ca2+; HH, Hypoxia/High Ca2+. (D) Primer
treatment (p=0.016). (E) Similar decline is characteristic forHif1α-003whilst with lower pr
primer sets speciﬁc for all Hif1α splice variants (001/001b/002/003) did not show any chang
under hypoxia. High standard deviations on this graph (attributed to just one experiment ou
Ca2+ and p=0.537 for high Ca2+). (I) The level of Hif2α mRNA expression appeared to b
experiments n=4. One * denotes changes with 0.01bpb0.05 while ** denotes highly signion N-TERT keratinocyte nuclear lysates obtained after 3 and 24 h of
cell exposure to hypoxia along with corresponding normoxic controls.
Nuclear lysates were obtained as recommended by the TransAM
protocol using the nuclear extraction kit from Active Motif (40010)
followed by protein quantiﬁcation using the Prostain Protein
Quantiﬁcation kit (15001; Active Motif, Rixensart, Belgium). Trans-
activation potential was assessed at four different experimental
settings as described above. Shown results represent means and
standard deviations from cells set up in triplicate on three occasions.
3. Results
3.1. Hypoxia-induced changes in HIF pathway-related genes as revealed
by microarray
Hypoxia effects on expression of genes related to HIF machinery
are shown in Table 1. Hif1α is represented by four probe sets on the
Affymetrix mouse genechip array. Three of them showed statisticallyocytes as shown by qPCR. (A) Schematic representations of exon–intron structure of the
ntal bars depicting the location of primers with letters to link to the qPCR data shown
xia period (0–5 h) falls down in two steps—between 1 and 2 (p=0.034) and after 5 h of
-003 showed that after prolonged exposure (48 h; chronic hypoxia) expression of these
alcium status (p=0.026 for low Ca2+ and p=0.063 for high Ca2+). NL, Normoxia/Low
s speciﬁc exclusively for Hif1α -001 showed a decline in its mRNA after 18 h of hypoxia
obability (p=0.094) due to high variability of normoxicHif1α-003 levels. (F and G) Two
es. (H)Hif1α-002 speciﬁc primers located in its 3′UTR showed an increase of mRNA level
t of four performed) notably affect the signiﬁcance of these changes (p=0.387 for low
e negligible under normoxic conditions and unchanging under hypoxia. For all qPCR
ﬁcant changes with pb0.01.
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of hypoxia appeared to be Ca2+-independent. Surprisingly, the Hif1α-
speciﬁc probe sets showed differences not only in the magnitude of
regulation but also in the direction of the change: probe set
1431981_at speciﬁc for Hif1α-002 splice variant was strongly and
positively regulated by hypoxia (+2.73 and+2.11 fold change at low
and high Ca2+ respectively with pb0.0075) while probe sets
1448183_a_at and 1416035_at, both speciﬁc for Hif1α-001 and
Hif1α-003 splice variants, showed a modest but statistically signiﬁ-
cant decrease under hypoxia (between −1.46 and −1.66 fold).
Hif2α (Epas1, two probe sets) showed no signiﬁcant changes in all
combinations of Ca2+ and oxygenation while Hif3α revealed strong
Ca2+-independent induction by hypoxia (three probe sets speciﬁc for
Hif3α-002 splice variant out of six total; Table 1).
Arnt, Arnt2, and Hif1an (Fih1) showed no signiﬁcant changes in
mRNA levels neither under hypoxia nor at low or high Ca2+. Arntl
mRNA was moderately upregulated under hypoxic conditions at both
low and high Ca2+ concentrations (between +1.61 and +1.80 fold).
In contrast, Arntl2 mRNA showed a statistically signiﬁcant decline
under hypoxia (between −1.54 and −1.88 fold), thus negatively
mirroring the changes in Arntl expression.
Surprisingly, only a few conventional HIF1 targets showed strong
and statistically signiﬁcant induction by hypoxia in PMK. Among them
Selenbp1 (+25.66 fold) which was recently shown to be a direct HIF1
target in mouse epidermal keratinocytes [34] as well as Higd1a
(+3.17 fold) and Vegfa (+4.02 fold), both representing classical HIF1
targets. Other Vegf isoforms (Vegfb and Vegfc) as well as Epo
(erythropoietin) and Nos (nitric oxide synthase) genes both known
as direct HIF1 targets [35,36] revealed no changes in hypoxic PMK at
both low and high Ca2+ with the only exception of Vegfc whichFig. 3. Effects of hypoxia on Hif1alpha protein level (Western blotting). (A and B) Hif1α prote
and during acute stage of hypoxia (up to 5 h). Quantiﬁcation of three different blots by den
gradual decline. (C) At 48 h of PMK exposure to hypoxia, the level of Hif1α protein was lowe
are replaced by a single 105 kDa band. (D) In human N-TERT keratinocytes, the level of HIF1α
95 and 110 kDa. (E and F) Analysis of nuclear and cytoplasmic lysates of PMK and N-TERT k
cytoplasmic fractions of normoxic cells (mostly represented by 95 kDa band) and its near c
prominent, especially in N-TERT cells. All blots are representative of samples taken on twoshowed moderate (1.88 fold) statistically signiﬁcant increase in
response to hypoxia under high Ca2+ conditions (for one probe set
only).3.2. Effects of hypoxia upon expression of different HIF factors as
revealed by qPCR and Western blotting
Hif1α was detectable in normoxic (21% O2) PMK at both mRNA
and protein levels (Figs. 2B–H and 3A–C and E). According to qPCR
results obtained with primers speciﬁc for both Hif1α-001 and -003
splice variants, the level of Hif1α mRNA in normoxic keratinocytes is
quite high (comparable to B2M housekeeping gene expression) and
not responsive to Ca2+ (Fig. 2B and C). Under hypoxia, the combined
mRNA level of Hif1α-001/003 splice variants decreased signiﬁcantly.
This decreasewas not gradual but took place in two prominent steps—
the ﬁrst decrease was detected between 1 and 2 h and a further
decrease was detected after 5 h of exposure with expression
remaining steady between 0 and 1 h and between 2 and 5 h of
hypoxia exposure (Fig. 2B). The use of primers speciﬁcally detecting
Hif1α-001 or Hif1α-003 (Fig. 2D and E) showed that the normoxic
level of Hif1α-001 is about 10 fold higher than Hif1α-003 and is
comparable to B2M, thus suggesting that the two-step decline ofHif1α
mRNA shown in Fig. 2B is mostly attributed to the Hif1α-001 splice
variant. The use of primers detecting Hif1α-001 and Hif1α-003 splice
variants showed that they both are negatively regulated by hypoxia
(Fig. 2D and E) and in Ca2+-independent manner (Fig. 2C). These
ﬁndings are matching a statistically signiﬁcant downregulation by
hypoxia of probe sets 1448183_a_at and 1416035_at (Table 1) which
are speciﬁc for both Hif1α-001 and Hif1α-003 splice variants.in is detected in PMKwhole cell lysates as a double band of 95 and 110 kDa in normoxia
sitometry showed increase of protein level during ﬁrst 2–3 h of exposure and then its
r compared to normoxic controls regardless of Ca2+ status. Hif1α-speciﬁc double bands
protein also declined by 48 h of exposure but it was still represented by double bands of
eratinocytes exposed to hypoxia for 48 h (low Ca2+) showed the high level of HIF1α in
omplete abolishment under hypoxia. Decline of nuclear Hif1α in hypoxia was not that
or three occasions in duplicate.
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we mentioned above, the Affymetrix probe set 1431981_at which is
exclusive for this splice variant showed strong upregulation by hypoxia
in contrast to other probe sets speciﬁc for Hif1α splice variants 001 and
003. qPCRwith primers positioned inHif1α exons 2–3 and 5–6 and thus
recognizing all three splice variants showed no apparent difference
between hypoxic and normoxic samples (Fig. 2F andG), suggesting that
the downregulation of splice variants 001 and 003 under hypoxia (Fig.
2D and E) may be compensated by upregulation of splice variant 002.
This suggestion is indirectly supported by the microarray results.
Nevertheless, the use of the primers speciﬁc to the proposed 3′ UTR of
splice variant 002 (Fig. 2H) demonstrated low level expression in
normoxic samples (1/30 of Hif1α-001) and only a modest increase
under hypoxia statistically signiﬁcant in three out of four samples.
Primers positioned in exon 6/3′ UTR of Hif1α-002 also showed a very
low level of expression, making the data not suitable for comparative
analysis but the obtained results clearly demonstrated that Hif1α-002
splice variant is certainly transcribed in epidermal keratinocytes and is
not downregulated by hypoxia in contrast to Hif1α-001 and Hif1α-003.
Verifying these results at protein level is currently impossible due to the
lack of splice variant-speciﬁc antibodies.Fig. 4. Differential regulation of Hif3α splice variants by hypoxia (1% O2 for 18 h) in PMKs (l
the different splice variants of Hif3α with legend and indication of primer location as on
(negligible) level of corresponding mRNA in normoxic samples and its noticeable (but statis
001/002/NEPAS showed higher level of mRNA compared to Hif3α-001 alone (but still much
increase of corresponding product under hypoxia. These changes can be attributed solely
represented by any Affymetrix probe set, showed very high expression level (comparable t
decline under hypoxia. For all qPCR experiments n=4. One * denotes changes with 0.01bpFor Hif1α Western blotting we used a GeneTex antibody
(GTX30647) developed against amino acids 432–528 of human
HIF1α. Therefore, this antibody would not detect the presumptive
protein product of Hif1α-002 splice variant which is lacking the C-
terminal half of Hif1α and is only 258aa-long. As shown by our WB
results, Hif1α protein was clearly detectible in normoxia as a double
band of 95 and 110 kDa, possibly representing 001 and 003 splice
variants. During the acute phase of hypoxia the Hif1α level
signiﬁcantly increased reaching a maximum at 2–3 h of exposure
and then gradually declined back to initial normoxic level (Fig. 3A and
B). In contrast to the acute phase (1–5 h) of PMK exposure to hypoxia,
by 48 h Hif1α protein was detected in whole cell lysates as a single
≈105 kDa band of low intensity (Fig. 3C). In whole cell lysates of N-
TERT keratinocytes exposed to hypoxia for 48 h HIF1α protein was
detected as a barely visible but still double band (Fig. 3D). Ca2+
concentration showed no effect on these changes.
Independent assessment of cytoplasmic and nuclear extracts
(low Ca2+) revealed that at normoxic conditions HIF1α protein is
detectable in the nucleus and cytoplasm of both PMK and N-TERT
cells with most Hif1α detected in the cytoplasm (Fig. 3E and F).
Exposure to hypoxia (48 h) resulted in the complete absence ofow Ca2+) as shown by qPCR. (A) Schematic representations of exon–intron structure of
Fig. 2. (B) qPCR with primers speciﬁc for Hif3α-001 splice variant showed very low
tically not signiﬁcant, p=0.504) increase under hypoxia. (C) Primers speciﬁc for Hif3α-
lower compared to B2M) in normoxic samples and statistically signiﬁcant (p=0.005)
to Hif3α-002 splice variant. (D) Primers speciﬁc for Hif3α-003, a splice variant not
o B2M) in normoxic samples and prominent, highly statistically signiﬁcant (p=0.002)
b0.05 while ** denote highly signiﬁcant changes with pb0.01.
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and N-TERT cells Hif1α remains unchanged (Fig. 3E and F).
In contrast to Hif1α, Hif2α mRNA level assessed by qPCR was very
low in normoxia (20–100 fold less compared to Hif1α or B2M) and
remained steady, showing no response to hypoxia (Fig. 2I), thus
matching microarray results (Table 1). All attempts to detect Hif2α
protein in primary mouse keratinocytes using an Abcam antibody
(Ab199; Table 3) were unsuccessful.
The mRNA level of Hif3α-001 splice variant in PMK at both
normoxia and hypoxia (up to 18 h of exposure) appeared to be at the
qPCR detection limit (Fig. 4B). The primer pair speciﬁc for both Hif3α-
001 and 002/NEPAS splice variants yielded approximately 25 fold
more expression at normoxic conditions as compared to Hif3α-001
splice variant alone (but still low as compared to B2M). Given the
negligible level of the Hif3α-001 splice variant, the level of normoxic
expression shown on Fig. 4C can mostly be attributed to the Hif3α-
002/NEPAS which was signiﬁcantly induced by hypoxia (about 2.5
fold). This qPCR result precisely matches the microarray data since all
Affymetrix probe sets showing statistically signiﬁcant increases under
hypoxia (between +1.67 and +5.23 fold; Table 1) are speciﬁcFig. 5. Effects of hypoxia on expression of ARNT. (A) Arnt2 mRNA is detectable in normoxic
was slightly elevated at 18 h of exposure. (B) Arnt is expressed in PMKs at much higher
prolonged hypoxia and (C) showed no response to Ca2+ (legends are as in Fig. 2C). For all qPC
changes in whole cell lysates during acute (0–5 h) exposure of keratinocytes to hypoxia as sh
Western blotting of whole cell lysates of PMK (F) and N-TERT (G) showed signiﬁcant declin
status. The blots shown are representative of samples taken on two occasions in duplicate. (H
high level of Arnt in the nuclear fraction of normoxic keratinocytes. The level of Arnt in norm
Nuclear fraction of Arnt was barely affected by hypoxia in mouse keratinocytes. Ca2+ status
results in signiﬁcant decline of both nuclear and cytoplasmic ARNT fractions. Surprisingly,
irrespectively of oxygen level. The blots are representative of samples taken on two occasioexclusively for theHif3α-002/NEPAS splice variant. It was not possible
to design qPCR primers speciﬁcally detecting NEPAS due to lack of
information pertaining to the similarity between NEPAS and Hif3α-
002.
Surprisingly, the expression of Hif3α-003 (which appeared to be
the most abundant Hif3α splice variant in normoxic PMK) was
signiﬁcantly (more than 3 fold) suppressed by hypoxia (Fig. 4D).
However, none of the Affymetrix probe sets is speciﬁc for Hif3α-003
and therefore these results could not be veriﬁed by another mean of
analysis.
The mRNA level of IPAS isoform in PMK at both normoxia and
hypoxia (up to 18 h of exposure) appeared to be negligible (data not
shown).
3.3. qPCR and WB assessment of Arnt expression under hypoxic
conditions
At the mRNA level, Arnt expression in PMK was relatively high
(about 20% of B2M expression level) and stable regardless of Ca2+ or
oxygenation levels in both short-term (0–5 h) and long-term (48 h)PMK but at very low level. It showed no response to acute hypoxia (0–5 h at 1% O2) but
level (about 1/6 of B2M). Its mRNA level remained unchanged under both acute and
R experiments n=3. (D and E) The level of Arnt protein in PMK did not show signiﬁcant
own byWestern blot repeated three times in duplicate and quantiﬁed by densitometry.
e of ARNT protein level at delayed (48 h) stage of hypoxia exposure, regardless of Ca2+
)Western blots of nuclear and cytoplasmic lysates of PMK at low and high Ca2+ showed
oxic cytoplasmwas lower and it was completely abolished by 48 h exposure to hypoxia.
had no apparent effect on the results. (I) In N-TERT keratinocytes at low Ca2+, hypoxia
high Ca2+ conditions resulted in complete abolishment of cytoplasmic ARNT fraction
ns in duplicate.
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Arnt protein (a single 87 kDa band) also does not show signiﬁcant
changes during acute hypoxia (0–5 h) in total PMK cell lysates while
increased variability was observed at 4–5 h time points (Fig. 5D and
E). Nevertheless, at 48 h of exposure to hypoxia Arnt protein is nearly
abolished in PMK and signiﬁcantly downregulated in N-TERT cells
irrespective of Ca2+ level (Fig. 5F and G).
Assessment of nuclear and cytoplasmic protein fractions in PMK
and N-TERT cells revealed that in normoxia ARNT is predominantly
nuclear. Hypoxia (48 h) had no obvious effect on Arnt level in the
nuclei of PMK but resulted in its complete absence from the cytoplasm
regardless of Ca2+ level (Fig. 5H). In contrast to PMK, in hypoxic N-
TERT cells, ARNT level was moderately decreased not only in the
cytoplasm but in the nucleus as well. Surprisingly, culturing of N-TERT
cells at high Ca2+ conditions resulted in the complete abolishment of
cytoplasmic ARNT in both normoxic and hypoxic cells (Fig. 5I).
As shown by qPCR, in PMK the mRNA level of Arnt2 is
approximately 40 fold lower compared to Arnt but is also steady
and showed no changes under hypoxia (Fig. 5A). Western blotting
failed to reveal Arnt2 positivity in either PMK or N-TERT cells
irrespective of hypoxia or Ca2+ levels (data not shown). These results
match the microarray data (Table 1).
3.4. Functional assay of Hif1 activity
HIF1 transcriptional activity was shown in normoxic N-TERT
keratinocytes (Fig. 6A). These ﬁndings are in line with the presence of
HIF1α and ARNT proteins in the nuclear fraction of normoxic cells.
Hypoxia (1% O2) resulted in a signiﬁcant increase in HIF1 activity
(about 3 fold) after 3 h—the time of maximal increase of HIF1α and
high ARNT protein levels (Figs. 3A and 5D and E). By 24 h of exposure
to hypoxia, HIF1 activity fell back to the initial (normoxic) level inFig. 6. HIF1 transcriptional activity in normoxic and hypoxic human N-TERT keratinocytes
nuclear lysates prepared after 3 and 24 h of hypoxia and from appropriate normoxic controls
increased during acute hypoxia stage (at 3 h) and declined again at 24 h of exposure. Ca2+ h
VEGFamessage in normoxic samples and its prominent increase during delayed (chronic) p
(48 h of hypoxia) showed identical results for VEGFa at protein level. For all graphs the lege
from cells set up in triplicate on three occasions. Panel (D) summarises the changes in Hif1α a
mRNA is much more abundant compared to Arnt in normoxic samples and is signiﬁcantly (
represents normoxia, while for bars “0.5-1 h” and “2-5 h” we pooled data from two and fouaccordance with signiﬁcant decline in expression of both HIF1α and
ARNT under prolonged hypoxia. All these effects were not modulated
by Ca2+.
Although Hif1α/Arnt protein levels and HIF1 transcriptional
activity both fall down under prolonged hypoxia, the mRNA level of
certain classical HIF1 targets such as Vegfα remained signiﬁcantly
elevated compared to normoxic cells at 18 h (microarray; Table 1) and
even at 48 h of exposure (qPCR; Fig. 6B). This prolonged increase in
VEGFα expression was also reﬂected at the protein level as shown by
ELISA (48 h of hypoxia treatment; Fig. 6C). Ca2+ concentration had no
effect on VEGFα transcription (Table 1; Fig. 6B), HIF1 TransAm assay or
VEGFα ELISA (Fig. 6A and C). The decline of HIF1 transcriptional
activity under prolonged hypoxia (Fig. 6A) was associated with two-
step drop of HIF1α mRNA level, while Arnt message remained steady
(Fig. 6D).4. Discussion
The level of oxygenation is a speciﬁc feature of cellular microen-
vironment which is essential for the proper maintenance of
differentiation programme in epidermal keratinocytes [37]. In
addition to the response to local hypoxia, the epidermis is able to
sense changing ambient oxygen and enable a whole body response to
these changes [31,38]. Local and systemic responses to the level of
oxygenation are primarily regulated through the HIF pathway which,
therefore, should be tightly regulated by hypoxia in the epidermis.
Signiﬁcant data suggest that proper HIF activity is essential for normal
skin functions and its deregulation is linked to pathogenesis of
common skin disorders such as psoriasis, melanoma and other skin
cancers [26,39,40]. Nevertheless, the mechanisms controlling epider-
mal HIF machinery are still obscure and have yet to be unravelled.. (A) HIF1 transactivation potential was assessed using the TransAm assay in N-TERT
. Relatively high HIF1 activity was detected in normoxic samples; it was signiﬁcantly (**)
ad no effect on TransAm assay readings. (B) qPCR analysis revealed substantial level of
hase of keratinocytes exposure to hypoxia (48 h). No effect of Ca2+ was seen. (C) ELISA
nds are exactly as in Fig. 2C. All results (A–C) represent means and standard deviations
nd ArntmRNA levels throughout the course of hypoxia treatment and shows that Hif1α
**) downregulated in two-step pattern while Arnt mRNA remains steady. The bar “0 h”
r time points, respectively, when Hif1α mRNA level remains unchanged.
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High levels of both Hif1α and Arnt expression in keratinocytes
cultured at 21% O2, as well as TransAM data and nuclear localization of
these proteins in normoxic cells suggest that Hif1 transcriptional
activity is a characteristic feature of the epidermis not only under
hypoxia but under normal physiological conditions as well. Since the
transcriptional level of Hif1α splice variants 002 and 003 appeared to
be negligible at 21%O2, Hif1 activity in normoxic keratinocytes is
largely maintained by the Hif1α-001 isoform which is expressed at a
level comparable to the B2M housekeeping gene. The ability of ARNT
to form transcriptionally active homodimers [41] and the recently
reported anti-bacterial role of Hif1α [42] also support our proposition
that HIF pathway has an oxygen-independent function in the
epidermis. Nevertheless, the potential difference between down-
stream targets of Hif1α/Arnt activity in hypoxic and normoxic
keratinocytes as well as the mechanisms activating HIF pathway in
the epidermis in vivo remain to be elucidated. Our results showed that
Ca2+ concentration (and presumably keratinocyte differentiation
status) is not among the factors affecting Hif/Arnt protein level and
activity in both mouse and human keratinocytes. Yet the reverse
(effects of Hif/Arnt activity on keratinocyte differentiation) is still a
possibility. Our recent ﬁndings that Arnt deﬁciency in mouse
epidermis results in severe deregulation of differentiation and in
barrier defects [30] further support the hypoxia-independent role of
Hif/Arnt in maintenance of epidermal homeostasis.
4.2. Hif1a splice variants are differentially regulated by hypoxia while
total Hif1a mRNA is suppressed in a stepwise pattern
The post-translational control of HIF1α level is widely accepted as
the major means of induction and maintenance of the hypoxia
response [e.g., 18]. However, our results have shown that in epidermal
keratinocytes HIF1α is strongly regulated by hypoxia at the
transcriptional level as well, especially during remote (chronic)
stage of exposure.
The analysis of Hif1α expression is complicated by the existence of
several splice variants of the gene, coding for isoforms with
potentially different functions. In our work we used the splice variant
sequence data and nomenclature provided by the Vertebrate Genome
Annotation (VEGA) genomic data repository (http://vega.sanger.ac.
uk/index.html) which was developed by the Wellcome Trust Sanger
Institute using Ensembl codebase [43]. VEGA identiﬁes three protein-
coding Hif1α splice variants designated as 001, 002, and 003. Hif1α-
001 corresponds to 836 amino acid-long isoform [44]. This splice
variant is known to be expressed in different mouse organs with
highest level in the heart, brain and kidney and low levels of
transcription in skeletal muscles and testis.
Hif1α-003 corresponds to a variant possessing an alternatively
spliced exon 1which is 12aa shorter and located nearly 7 kb upstream
compared to exon 1 of the Hif1α-001 [45]. As a result, these two splice
variants have not only a different ﬁrst exon but their transcription is
driven by different promoters [8]. Hif1α-003 also possesses a 42nt
shorter exon 11 and therefore the total length of the corresponding
isoform is 810aa only. This splice variant was previously designated as
I.1 and was shown to be tissue-speciﬁc with predominant expression
in lymphoid organs (spleen and thymus) and testis [8,10,46].
A Hif1α splice variant bearing a longer version of exon 1 (identical
to Hif1α-001) but a shorter exon 11 (identical to Hif1α-003) and
therefore coding for a 822aa-long isoform [47] is not shown in the
VEGA data repository. To avoid further confusions and to stay with the
VEGA nomenclature we designate this splice variant as Hif1α-001b
since it shares the same promoter with Hif1α-001. In the literature,
Hif1α-001b is commonly designated as a ubiquitously expressed I.2
splice variant [9,44] but its obvious difference with Hif1α-001 (loss of
42 nucleotides in exon 11) is usually ignored. Hif1α-001 (long) andHif1α-003 (short) Hif1α isoforms possess similar DNA binding and
transcriptional activities [10]. Nevertheless, it was shown that
activation of T lymphocytes results in speciﬁc upregulation of the
Hif1α-003 (I.1) isoform, while Hif1α-001b (I.2) (and Hif1α-001?)
remain unaffected [10], suggesting a potential functional difference
between them. Under normal conditions, Hif1α-001 represents the
most prevalent isoform of Hif1α in majority of tissues and organs [11].
Our data showed that this is also the case for epidermal keratinocytes:
Hif1α-001 appeared to be the major “normoxic” Hif1α splice variant
exceeding the level of Hif1α-003 approximately 10 times. Under
certain conditions, Hif1α-003 (which normally constitutes not more
than 4% of Hif1α transcripts) may be signiﬁcantly induced reaching
the levels comparable withHif1α-001 [11]. According to our results, in
epidermal keratinocytes hypoxia is not among these inductive factors
since it signiﬁcantly down-regulates mRNA level of both Hif1α-001
and Hif1α-003 (Fig. 2D and E).
Previously it was shown that in mouse Hepa1 cells hypoxia (1%O2)
results in a prominent decrease of Hif1α-001 steady-state mRNA level
after 16 h, while no decrease was reported during acute stage of
exposure [48]. In PMK, we observed a strong decline of Hif1α-001
mRNA (about 50%) between 1 and 2 h of hypoxia exposure (Fig. 2B).
After that the mRNA level remained stable for several hours and then
dropped dramatically (about ﬁve fold by 48 h of exposure), exactly as
it was previously reported for delayed stage of hypoxia treatment in
Hepa1 cells [48,49]. Down-regulation of Hif1α-001 mRNA by hypoxia
in a stepwise pattern with two prominent drops in its level is
suggestive of two different mechanisms implicated in control of
Hif1α-001 transcription in epidermal keratinocytes. We propose that
the ﬁrst quick-response decline of Hif1α-001mRNA (possibly through
mRNA decay [50,51]) may be not dependent on protein synthesis,
while the second decline (during chronic stage of exposure) is
probably controlled by hypoxia-initiated translation of novel proteins
and therefore requires time to be employed.
Activation of HIF pathway by hypoxia while adaptive in acute
phase is detrimental for cell survival in the long run [52,53]. Therefore,
we assume that quick and robust downregulation of Hif1α-001 and
003 mRNA by hypoxia may represent a back-up mechanism which
works in conjunction with post-translational mechanisms (e.g., PHD-
mediated proteasomal degradation) to bring down HIF activity
induced by acute hypoxia.
Another protein-coding Hif1α splice variant shown on the VEGA
web site, Hif1α-002 is formed due to alternative splicing in intron 6–7
and creation of a new stop codon. This results in the formation of a
truncated 258aa-long isoform possessing only the ﬁrst six exons of
mouse Hif1α and therefore missing the oxygen-dependent degrada-
tion domain (ODDD; Fig. 1). To our knowledge, the expression and
activity of this Hif1α splice variant has never been discussed in the
literature. At the same time, translation of the Hif1α-002 isoform in
mouse tissues is conﬁrmed by several large-scale genomic studies as
evident from UCSC Genome Browser and NCBI websites (uc007nwp.1
and AK017853.1 respectively). Analysis of the qPCR melting curve
obtained using Hif1α-002-speciﬁc primers in normoxic epidermal
PMK (not shown) revealed a single and sharp peak, suggesting the
presence of corresponding transcriptional product of this splice
variant. Nevertheless, the level of transcription appeared to be rather
low—about 1/30 of Hif1α-001 (but comparable to Hif1α-003).
Surprisingly, under hypoxia, in contrast to Hif1α-001 and Hif1α-003
splice variants, Hif1α-002 showed signiﬁcant upregulation. Moreover,
the use of primer pairs speciﬁc for all Hif1α splice variants revealed no
difference in expression level between normoxia and hypoxia (Fig. 2F
and G), suggesting that evident downregulation of Hif1α-001 and
Hif1α-003 under hypoxia (Fig. 2C–E) is compensated by concom-
itant upregulation of Hif1α-002 and possibly other still unidentiﬁed
Hif1α splice variant(s). Importantly, the putative protein encoded
by the Hif1α-002 should be spared from pVHL-mediated proteaso-
mal degradation due to the lack of oxygen-dependent degradation
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mRNA) may account (along with Hif1α-001) for hypoxia-indepen-
dent functions attributed to Hif1α. Together with the apparent
upregulation of Hif1α-002 transcription by low oxygen, presump-
tive stability of corresponding protein may lead to a signiﬁcant
accumulation of the Hif1α-002 isoform in hypoxic epidermal
keratinocytes. Evaluation of the potential physiological signiﬁ-
cance of this scenario requires availability of isoform-speciﬁc Hif1α
antibodies.
The double band for Hif1α protein, revealed by Western blotting
(Fig. 3A, C, and D), may correspond to different isoforms of this
protein simultaneously expressed in normoxic PMK. Disappearance of
the 95 and 110 kDa bands and their replacement by a single 105 kDa
band under prolonged hypoxia may reﬂect differential regulation of
Hif1α splice variants by low oxygen revealed by our results
(replacement of Hif1α-001/003 by Hif1α-002). Unfortunately, the
lack of isoform-speciﬁc antibodies and impossibility to develop Hif1α-
001b-speciﬁc primers impedes further clariﬁcation of this issue.
4.3. Hif2a plays no role in control of transcriptional activity in mouse
epidermal keratinocytes
In contrast to Hif1α which is not only actively produced by
epidermal keratinocytes but is also regulated by hypoxia, Hif2αmRNA
and protein are present in these cells at a negligible or undetectable
level under both normoxic and hypoxic conditions. Of interest,
erythropoietin (Epo) which is a classical hypoxia-responsive gene as
reported for many different tissues and cell types [35,54] did not
appear on our microarray. Compared to Hif1α, Hif2α is much more
efﬁcient in regulation of erythropoietin gene [55]. Thus, the lack of
Hif2α transcription in mouse epidermal keratinocytes may be linked
to Epo non-responsiveness to hypoxia in these cells and can explain
the virtual absence of Epo protein in PMK both in vivo and in vitro
[56,57]. Of note, other classical hypoxia targets – nitric oxide synthase
genes (Nos) – showed no response to hypoxia as well (Table 1). By
analogy with Epo gene, we presume that this may be also attributed to
the lack of Hif2α expression. The same may apply to the Epo receptor
(Epor; Table 1) which is also known to be induced by hypoxia in other
cell types [58] but showed no response to low O2 in PMK.
4.4. Hif3α-003 is the major Hif3a splice variant in normoxic epidermal
keratinocytes and is downregulated by hypoxia
Similarly toHif1α, theVEGAgenomic data repository identiﬁes three
protein-coding splice variants for mouse Hif3α designated as 001, 002,
and 003 (Fig. 4A). Hif3α-001 is coding for a 662aa-long protein
composed of 15 exons sharing signiﬁcant similarity with Hif1α.
Hif3α-002 (664aa) differs from 001 in that the ﬁrst 8aa are coded by
the alternative exon 1a and it has a much longer 3′UTR. Hif3α-003,
which shares the alternative exon 1a with Hif3α-002, has differentially
spliced exons 3 and 4 and lacks the ODDD andN-TAD,1 thus coding for a
shortest (152aa) Hif3α isoform. In the literature, three different Hif3α
splice variants are usually referred to as theHif3α itself [61] (662aa-long
isoform identical to VEGA's Hif3α-001); NEPAS coding for 664aa-long
isoform [17] and probably identical to VEGA's 002 splice variant; and
inhibitory PAS domain protein—IPAS, coding for a 307aa-long isoform
[16,62].While IPAS shares a signiﬁcant similaritywith a shortHif3α-003
splice variant (i.e., the same alternative exon 1a and lack of transactiva-
tion and protein stability domains; Fig. 4A) it bears several additional1 Lack of C-TAD is characteristic for all Hif3α isoforms which, nevertheless, does not
impede their efﬁcient hydroxylation by Egln/PHDs [59,60].exons and a different 3′UTR. Thus, based on available data, we assume
the existence of four protein-coding splice variants of Hif3α: 001, 002/
NEPAS, 003 and IPAS.
Despite our data showed signiﬁcant increase of Hif3α-001 and
Hif3α-002/NEPAS mRNAs under low O2, the level of expression of
these two splice variants in both normoxic and hypoxic epidermal
keratinocytes was very low (at the level of detection for Hif3α-001),
suggesting that they play no or little role in epidermal Hif3α activity.
In contrast, the use of primers speciﬁc for both Hif3α-003 and IPAS
showed a very high level of normoxic signal (comparable to B2M) and
strong (about 4 fold) downregulation under hypoxia (Fig. 4D). Mouse
IPAS plays an important role in the negative control of Hif1 activity by
forming inoperative heterodimers with Hif1α; however, previously it
was shown to be positively regulated by hypoxia [16,63]. The use of
IPAS-speciﬁc primers revealed a very low level of this splice variant
(at qPCR detection limit, not shown), thus suggesting that the
signiﬁcant level of Hif3α normoxic message in PMK and its down-
regulation by hypoxia (Fig. 4D) is mostly (if not entirely) attributed to
the Hif3α-003 splice variant. Limited information on Hif3α-003
structure does not allow developing primers speciﬁc exclusively to
this splice variant. Additionally, none of the Affymetrix mouse
genechip probe sets pick out Hif3α-003. Thus, despite Hif3α-003
appearing to be the major Hif3α splice variant in epidermal
keratinocytes, there is limited scope to gain further insight into the
functional role of this speciﬁc isoform and its robust control by
hypoxia in the these cells.4.5. Effects of hypoxia upon Arnt level and HIF1 (Hif1a/Arnt) activity
In line with previous reports claiming that, in contrast to Hif1α,
Arnt is not regulated by hypoxia [1,64] we found no apparent changes
in Arnt mRNA during acute and delayed (48 h) stages of keratinocytes
exposure to low O2. The changes in the level of Arnt protein were also
not signiﬁcant during acute hypoxia (up to 5 h). Nevertheless, under
chronic hypoxia it appeared to be considerably reduced in human and
abolished in mouse epidermal keratinocytes (Fig. 5F and G). The
mechanism of this decline remains unknown but downregulation of
Arnt at the protein and not at the message level suggests that
prolonged hypoxia triggers post-translational degradation of Arnt.
Thus, our data on the dynamics of Hif1α and Arnt expression in
mouse and human keratinocytes suggest that HIF1 transcriptional
activity should be substantial in normoxic cells, should instantly
increase in acute hypoxia and drop down below the initial level in
chronic hypoxia. This scenario is strongly supported by the results of
our HIF1 TransAm assay (Fig. 6A). At the same time, while Hif1α and
Arnt levels (and concomitant HIF1 activity) are signiﬁcantly down-
regulated in epidermal keratinocytes under prolonged hypoxia, the
expression of classical hypoxia targets such as Vegfa continues to be
maintained at high level (bothmRNAandprotein). Similar effectswere
described for hypoxia-inducible glycolytic enzyme aldolase A inmouse
Hepa1 cell line [49] and for erythropoietin in human tissues under
chronic hypoxia at high altitude [65]. These ﬁndings suggest that
keratinocyte response to prolonged hypoxia is regulated by factors
other than HIF1 which still await identiﬁcation. Of note, our results
revealed no principal difference in regulation of HIF machinery by
hypoxia between mouse and human keratinocytes.
All together, our ﬁndings shed new light on the role of HIF
machinery in maintenance of epidermal homeostasis and also
highlight the multifaceted and diverse nature of mechanisms
controlling HIF activity in mouse and human epidermis.Acknowledgments
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